Browsing Tag
Alcon
6 posts
Why Alcon raised its bid for STAAR Surgical and dropped matching rights in amended merger deal
Find out how Alcon raised its cash bid for STAAR Surgical and removed matching rights to secure a $1.6 billion refractive-technology acquisition.
Will shareholder pressure derail the STAAR–Alcon merger? Why Yunqi Capital wants the deal scrapped
Yunqi Capital is urging STAAR Surgical to end the Alcon deal delay and explore stronger alternatives—find out why the pressure is mounting now.
Alcon’s Clareon Vivity IOL gains CE Mark approval, expanding vision correction options in Europe
Discover how Alcon’s Clareon Vivity IOL is transforming cataract surgery with CE Mark approval, offering presbyopia correction and extended vision clarity in Europe.
Glenmark Pharmaceuticals expands U.S. OTC market presence with Olopatadine Eye Drops
Glenmark secures FDA approval for its OTC Olopatadine Hydrochloride eye drops, expanding its U.S. presence in the $50.7M allergy relief market.
Alcon acquires Aerie Pharmaceuticals to expand eye care business
Alcon, an American Swiss medical company specializing in eye care products, has closed the previously announced $930 million…
Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US
Alcon, a leading global eye care company, has introduced its AcrySof IQ PanOptix trifocal intraocular lens (IOL) in…